Shattuck Labs and the Dual-Action Promise of SL-325: A Closer Look
AI‑Designed Universal COVID‑19 Vaccine Enters Phase‑1 Trials
BPC‑157: The Scientist Who’s Ready to Talk Skeptics
A Glimmer of Hope: NKGen Biotech's Trocleucel Shows Remarkable Cognitive Gains in Parkinson's Trial
LB Pharma Ignites Wall Street with Dazzling Trading Debut, Shares Soar on Schizophrenia Drug Promise